Managing demand: transfer of management of self limiting conditions from general practice to community pharmacies.

controlling or cooperating with patients? Int J Cardiol 1995;47:257-68. 11 Krall R. Interactions of compliance and patient safety. In: Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991:19-25. 12 Sackett D, Haynes R, Gibson E, Taylor D, Roberts R, Johnson A. Patient compliance with antihypertensive regimens. Patient Couns Health Educ 1978;1:18-21. 13 Melnikow J, Kiefe K. Patient compliance and medical research: issues in methodology. J Gen Intern Med 1994;9:96-104. 14 Urquhart J. Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokinet 1994;27:202-15. 15 Guerrero D, Rudd P, Bryant-Kosling C, Middleton B. Antihypertensive medication taking: investigation of a simple regimen. Am J Hypertens 1993;6:586-92. 16 Mallion J, Dutrey C, Vaur L, Genes N, Renault M, Elkik F, et al. Benefits of electronic pill boxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens 1996;14:137-44. 17 Mallion J, Meilhac B, Tremel F, Calvez R, Bertholom M. Use of a microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment. J Cardiovasc Pharmacol 1992;19:S41-8. 18 O’Brien E, Aktins N, Mee F, O’Malley L. Comparative accuracy of six ambulatory devices according to blood pressure levels. J Hypertens 1993;11:673-5. 19 Altman D. How large a sample? In: Gore S, Altman D, eds. Statistics in practice. London: BMA, 1982:6-8. 20 Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4. 21 Andrejak M, Genes N, Vaur L, Poncelet P, Clerson P, Carre A. Electronic pill-box in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimen. Am J Hypertens 2000;13:184-90. 22 Waeber B, Gastone L, Kolloch R, McInnes G. Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study. J Hypertens 1999;17:1041-5. 23 Cramer J, Scheyder R, Mattson R. Compliance declines between clinical visits. Arch Intern Med 1990;150:1509-10. 24 Kruse W, Weber E. Dynamics of drug regimen compliance: its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 1990;38:561-5. 25 Leenen F, Wilson T, Bolli P, Larouchelle P, Myers M, Handa SP, et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol 1997;13:914-20. 26 Boissel J, Meillard O, Perrin-Fayolle E, Ducret T, Alamercery Y, Sassano P, et al. Comparison between a bid and tid regimen: improved compliance with no improved antihypertensive effect. The EOL research group. Eur J Clin Pharmacol 1996;50:63-7. 27 Waeber B, Vetter W, Darioli R, Keller U, Brunner H. Improved blood pressure control by monitoring compliance of antihypertensive therapy. Int J Clin Pract 1999;53:37-8. 28 McKenny J, Munroe W, Wright J. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol 1992;32:277-83.